The Clatterbridge Cancer Centre NHS Foundation Trust

Specialist MDT: Wirral University Teaching Hospital NHS Foundation Trust

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Isotope bone scan
  • Treatment Facilities:
    • External beam radiotherapy (EBRT)
    • High-dose rate brachytherapy
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
    • Clinical trials unit
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Psychological counselling

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here. Please note: the data quality results were amended in May 2022.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 563 939
Performance Status recorded 95% 97%
TNM completed 87% 87%
Stage variable assigned 95% 96%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 901 34801
Percentage of men diagnosed with metastatic disease 16% 13%

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset

Outcome

Treatment Centre
No. of men who received radical radiotherapy () 280
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 5%

Compare provider outcomes